Overview
The Center for Immuno-Oncology (CIO) of the Dana-Farber Cancer Institute (DFCI) is seeking a research scientist to join the Tissue Biomarker Laboratory (TBL). The laboratory is dedicated to the development and implementation of spatial analyses to study the tumor immune microenvironment in biopsies from patients undergoing immunotherapy treatments. The TBL carries out multiplex immunofluorescence workflows using Akoya and Lunaphore platforms and performs computational analyses to interpret these data. The research is highly collaborative with a wide range of investigators across DFCI Disease Centers and other institutions to address their experimental questions. Many studies seek to identify biomarkers of response or resistance to immunotherapy using spatial biology analyses (see https://ciopath.dfci.harvard.edu/ for more detail).
The Tissue Biomarker Laboratory provides pan-cancer clinical/translational correlative spatial biology studies and is an NIH-sponsored Cancer Immune Monitoring and Analysis Center. Over the past 5 years, the laboratory has contributed to over 50 publications (http://ciopath.dfci.harvard.edu/publications).
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Responsibilities
Responsibilities will include initiating and managing research projects, overseeing data collection and analysis, and working with the Principal Scientist and Faculty Director to prepare manuscripts and research proposals. Research projects will be collaborative studies involving extensive interactions with histopathology staff, research technicians, biomedical researchers, pathologists, clinicians, bioinformaticians, and data scientists. Experience working with teams and managing technicians is preferred.
A qualified candidate should have a PhD in a biomedical-related discipline, such as immunology, biomedical engineering, and/or cancer biology, and experience in or quantitative microscopy or computational data analysis.
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.

With a career at Dana-Farber Cancer Institute, you play an important role in helping to fulfill our mission and ultimate goal: the eradication of cancer and related diseases. We are ranked as one of the nation's best midsize employers and offer exciting jobs and careers to match your skills, interests, and passions.
The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases.
As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.